Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: R Salonen, E A Ashford, M Gibbs, H Hassani
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2426616986